Vnitr Lek 2023, 69(3):173-180 | DOI: 10.36290/vnl.2023.030

Clinical assessment and management of patients with multimorbidity

Zdeněk Monhart1, 2
1 Interní oddělení a urgentní příjem, Nemocnice Znojmo
2 Lékařská fakulta Masarykovy univerzity, Brno

Internal medicine specialists, also known as general internal medicine specialists are specialist physicians trained to manage particularly complex or multisystem disease conditions that single-organ-disease specialists may not be trained to deal with. The management of multimorbidity, however, is often complex, and requires specific clinical skills and corresponding experience in appropriate diagnostic and therapeutic procedures. Multimorbidity is associated with a decline in many aspects of health and in consequence with an increase in hospital admissions, polypharmacy, and use of health care and social resouces. When prescribing medicine to patients with multimorbidity, all the risks and benefits, as well as possible interactions should be carefully considered. The prescription appropriateness can be assessed by validated tools like STOPP-START criteria. Beneficial part of good prescribing is deprescribing - planned and supervised process of dose reduction or withdrawal of medications that are no longer needed in the circumstances of the patient.

Keywords: multimorbidity, polypharmacy, deprescribing.

Accepted: April 27, 2023; Published: May 16, 2023  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Monhart Z. Clinical assessment and management of patients with multimorbidity. Vnitr Lek. 2023;69(3):173-180. doi: 10.36290/vnl.2023.030.
Download citation

References

  1. Ho IS, Azcoaga‑Lorenzo A, Akbari A, et al. Variation in the estimated prevalence of multimorbidity: systematic review and meta‑analysis of 193 international studies. BMJ Open 2022;12:e057017. Go to original source... Go to PubMed...
  2. Hindricks G, Potpara T, Dagres N, et al. 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio‑Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC, Eur Heart J. 2021 Feb 1;42(5):373-498. Go to original source...
  3. Farmer C, et al. Clinical assessment and management of multimorbidity: summary of NICE guidance. BMJ. 2016 Sep 21;354:i4843. Go to original source... Go to PubMed...
  4. Barnett K, Mercer SW, Norbury M, et al. Epidemiology of multimorbidity and implications for health care, research, and medical education: A cross‑sectional study. Lancet,380,37-43. Go to original source... Go to PubMed...
  5. Valderas JM, Starfield B, Sibbald B et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357-363. Go to original source... Go to PubMed...
  6. de Groot V, Beckerman H, Lankhorst GJ, et al. How to measure comorbidity. a critical review of available methods. J Clin Epidemiol. 2003;56(3):221-229. Go to original source... Go to PubMed...
  7. Huntley AL, Johnson R, Purdy S, et al. Measures of multimorbidity and morbidity burden for use in primary care and community settings: a systematic review and guide. Ann Fam Med. Mar‑Apr 2012;10(2):134-41. Go to original source... Go to PubMed...
  8. Newschaffer CJ, Bush TL, Penberthy LT. Comorbidity measurement in elderly female breast cancer patients with administrative and medical records data, J Clin Epidemiol. 1997,50:725-733. Go to original source... Go to PubMed...
  9. Charlson ME, Charlson RE, Peterson JC, et al. The Charlson comorbidity index is adapted to predict costs of chronic disease in primary care patients. J Clin Epidemiol. 2008;61(12):1234-1240. Go to original source...
  10. Salvi F, Miller MD, Grilli A, et al. A manual of guidelines to score the modified cumulative illness rating scale and its validation in acute hospitalized elderly patients.J Am Geriatr Soc. 2008 Oct;56(10):1926-31. Go to original source... Go to PubMed...
  11. Donnan PT, Dorward DW, Mutch B, et al. Development and validation of a model for predicting emergency admissions over the next year (PEONY): a UK historical cohort study. Archives of Internal Medicine. 2008; 168(13):1416-1422. Go to original source... Go to PubMed...
  12. Hippisley‑Cox J, Coupland C. Predicting risk of emergency admission to hospital using primary care data: Derivation and validation of QAdmissions score. BMJ Open. 2013 Aug 19;3(8):e003482. Go to original source... Go to PubMed...
  13. Von Korff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45(2):197-203. Go to original source... Go to PubMed...
  14. Bernabeu‑Wittel M, Para O, Voicehovska J, et al; EFIM Multimorbidity Working Group. Competences of internal medicine specialists for the management of patients with multimorbidity. EFIM multimorbidity working group position paper. Eur J Intern Med. 2023 Mar;109:97-106. Go to original source... Go to PubMed...
  15. Lyness JM, Niculescu A, Tu X, et al. The relationship of medical comorbidity and depression in older, primary care patients.Psychosomatics. 2006;47(5):435-9. Go to original source... Go to PubMed...
  16. European guide for management of frailty at individual level including recommendations and roadmap. https://www.advantageja.eu/images/D6.2_EuropeanGuide_Management.pdf
  17. Butchart A, Kerr EA, Heisler M, et al. Experience and management of chronic pain among patients with other complex chronic conditions. Clin J Pain. 2009 May;25(4):293-8. Go to original source... Go to PubMed...
  18. Boyd CM, Darer J, Boult C, et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases. JAMA. 2005;294:716-24. Go to original source... Go to PubMed...
  19. Guthrie B, Payne K, Alderson P, et al. Adapting clinical guidelines to take account of multimorbidity. BMJ. 2012;345:e6341. Go to original source...
  20. Leśniak W, Morbidoni L, Dicker D, et al. EFIM Clinical practice guidelines adaptation for internists - an EFIM methodology.Eur J Intern Med. 2020;77:1-5. Go to original source... Go to PubMed...
  21. Kostev K, Jacob L. Multimorbidity and polypharmacy among elderly people followed in general practices in Germany. Eur J Intern Med. 2018 Sep;55:66-68. Go to original source... Go to PubMed...
  22. Masnoon N, Shakib S, Kalisch‑Ellett L, et al. What is polypharmacy? A systematic review of definitions. BMC Geriatr. 2017 Oct 10;17(1):230. Go to original source... Go to PubMed...
  23. Chang TI, Park H, Kim DW, et al. Polypharmacy, hospitalization, and mortality risk: a nationwide cohort study. Sci Rep. 2020 Nov 3;10(1):18964. Go to original source... Go to PubMed...
  24. Burt J, Elmore N, Campbell SM, et al. Developing a measure of polypharmacy appropriateness in primary care: systematic review and expert consensus study. BMC Med. 2018 Jun 13;16(1):91. Go to original source... Go to PubMed...
  25. The 2019 American Geriatrics Society (AGS) Beers Criteria® Update Expert Panel (2019). American Geriatrics Society 2019 Updated AGS Beers Criteria® for Potentially Inappropriate Medication Use in Older Adults. J Am Geriatr Soc. 2019 Apr;67(4):674-694. Go to original source... Go to PubMed...
  26. Naugler CT, Brymer C, Stolee P, et al. Development and validation of an improving prescribing in the elderly tool. Can J Clin Pharmacol. 2000 Summer;7(2):103-7.
  27. Barry PJ, Gallagher P, Ryan C, et al. START (screening tool to alert doctors to the right treatment) -an evidence‑based screening tool to detect prescribing omissions in elderly patients. Age and Ageing. 36(6):632-638. Go to original source... Go to PubMed...
  28. O'Mahony D. STOPP/START criteria for potentially inappropriate medications/potential prescribing omissions in older people: origin and progress. Expert Rev Clin Pharmacol. 2020 Jan;13(1):15-22. Go to original source... Go to PubMed...
  29. Pazan F, Weiss C, Wehling M. FORTA. The FORTA (Fit fOR The Aged) List 2021: Fourth Version of a Validated Clinical Aid for Improved Pharmacotherapy in Older Adults. Drugs Aging. 2022 Mar;39(3):245-247. Go to original source... Go to PubMed...
  30. Scott IA, Le Couteur DG. Physicians need to take the lead in deprescribing. Intern Med J. 2015 Mar;45(3):352-6. Go to original source... Go to PubMed...




Vnitřní lékařství

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.